• Company
• K-Bio speeds up novel drug development to treat MASH
• by Son, Hyung-Min Jul 15, 2024 05:47am

• Opinion
• [Reporter’s View] MFDS provides support for drug shortages
• by Lee, Hye-Kyung Jul 15, 2024 05:47am

• Policy
• Roche Korea speeds up reimb of Ocrevus in KOR
• by Lee, Tak-Sun Jul 12, 2024 05:48am

• Company
• Protein C deficiency drug 'Ceprotin' begins negotiations
• by Eo, Yun-Ho Jul 12, 2024 05:48am

• Policy
• Reassessing the plan for comparing foreign drug prices
• by Lee, Tak-Sun Jul 12, 2024 05:48am

• Company
• Will Epkinly become a game-changer in the blood cancer mkt?
• by Hwang, Byung-woo Jul 12, 2024 05:47am

• Policy
• ‘Bioequivalence tests rather intensified price cuts'
• by Lee, Tak-Sun Jul 12, 2024 05:47am

• Company
• "Enhertu gets expanded indication to treat lung cancer"
• by Son, Hyung-Min Jul 11, 2024 06:12am

• Company
• Will Trodelvy be deliberated for reimb by DREC in August?
• by Eo, Yun-Ho Jul 11, 2024 05:47am

• Policy
• Simulect in supply crisis with no alternative
• by Lee, Tak-Sun Jul 11, 2024 05:47am